EUVIMEDEUVIMED entdecken
Crossref

Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPS

Hirotaka Komaba iD, Junhui Zhao, Angelo Karaboyas, Suguru Yamamoto, Indranil Dasgupta, Mohamed Hassan, Li Zuo, Anders Christensson, Christian Combe, Bruce M Robinson, Masafumi Fukagawa

Journal of Bone and Mineral Research · 2023

DOI: 10.1002/jbmr.4913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Mineral Research, 2023. Verfasst von Hirotaka Komaba und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan. Hauptthemen laut MEDLINE: Hyperparathyroidism, Secondary, Hip Fractures, Vitamin D Deficiency. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: This manuscript was financially supported by Kyowa Kirin. Global support for ongoing DOPPS Programs is provided without restriction on publications by a variet….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Active vitamin D is commonly used to control secondary hyperparathyroidism in dialysis patients, but it is unknown whether active vitamin D directly improves bone strength, independently of its ability to suppress parathyroid hormone (PTH). We analyzed the association between the prescription of active vitamin D and incidence of any fracture and hip fracture in 41,677 in-center hemodialysis patients from 21 countries in phases 3 to 6 (2005 to 2018) of the Dialysis Outcomes and Practice Patterns Study (DOPPS). We used Cox regression, adjusted for PTH and other potential confounders, and used a per-protocol approach to censor patients at treatment switch during follow-up. We also used a facility preference approach to minimize confounding by indication. Overall, 55% of patients were prescribed active vitamin D at study enrollment. Event rates (per patient-year) were 0.024 for any fracture and 0.010 for hip fracture. The adjusted hazard ratio (95% confidence interval) comparing patients prescribed versus not prescribed active vitamin D was 1.02 (0.90 to 1.17) for any fracture and 1.00 (0.81 to 1.23) for hip fracture. In the facility preference approach, there was no difference in fracture rate between facilities with higher versus lower active vitamin D prescriptions. Thus, our results do not suggest a PTH-independent benefit of active vitamin D in fracture prevention and support the current KDIGO guideline suggesting the use of active vitamin D only in subjects with elevated or rising PTH. Further research is needed to determine the role of active vitamin D beyond PTH control. © 2023 American Society for Bone and Mineral Research (ASBMR).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, SecondaryHip FracturesVitamin D DeficiencyHumansVitamin DRenal DialysisParathyroid Hormone

Stichwörter der Autor:innen

ACTIVE VITAMIN DBONE METABOLISMFRACTUREHEMODIALYSISPARATHYROID HORMONESECONDARY HYPERPARATHYROIDISM

Substanzen

Vitamin DParathyroid Hormone

Autor:innen und Institutionen

  • Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
  • The Institute of Medical Sciences, Tokai University, Isehara, Japan.
  • Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
  • Division of Clinical Nephrology and Rheumatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
  • Renal Medicine, University Hospitals Birmingham, Birmingham, UK.
  • Warwick Medical School, University of Warwick, Coventry, UK.

ORCID-Profile: Hirotaka Komaba

Förderung

  • This manuscript was financially supported by Kyowa Kirin. Global support for ongoing DOPPS Programs is provided without restriction on publications by a variet…

Zitieren

APA

Komaba, H., Zhao, J., Karaboyas, A., Yamamoto, S., Dasgupta, I., Hassan, M., Zuo, L., Christensson, A., Combe, C., Robinson, B. M., & Fukagawa, M. (2023). Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPS. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.4913

Vancouver

Komaba H, Zhao J, Karaboyas A, Yamamoto S, Dasgupta I, Hassan M, et al. Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPS. Journal of Bone and Mineral Research. 2023. doi:10.1002/jbmr.4913

BibTeX
@article{Komaba2023,
  author = {Komaba, Hirotaka and Zhao, Junhui and Karaboyas, Angelo and Yamamoto, Suguru and Dasgupta, Indranil and Hassan, Mohamed and Zuo, Li and Christensson, Anders and Combe, Christian and Robinson, Bruce M and Fukagawa, Masafumi},
  title = {Active Vitamin D Use and Fractures in Hemodialysis Patients: Results from the International DOPPS},
  journal = {Journal of Bone and Mineral Research},
  year = {2023},
  doi = {10.1002/jbmr.4913}
}
Kostenlos starten →